Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

AbbVie Received FDA Approval for Venclexta for Efficacy Under NDA 208573 on Monday

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208573
byCharles Gross
October 5, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208573

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0